CALABASAS, Calif., Jan. 6, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc . (Nasdaq: KYTH ) today announced that Keith Leonard, president and chief executive officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
| Event: | 32nd Annual J.P. Morgan Healthcare Conference |
| Date: | Monday, January 13, 2014 |
| Time: | 8:30 a.m. PT |
A live webcast will be available under the Investors section of the Company's website at www.kytherabiopharma.com . The presentation will be archived on the website and will be available for at least 14 days.
About KYTHERA Biopharmaceuticals, Inc.
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's product candidate, ATX-101, is currently in late stage clinical trials for the reduction of submental fat, which commonly presents as a double chin, and is a potential first-in-class submental contouring injectable drug. KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring.
Investor Contact: Heather Rowe Associate Director, Investor Relations Tel: (818) 587- 4559